Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2009

01-08-2009 | Epidemiology

Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme

Authors: Sylvia B. F. Brown, David S. Morrison, Timothy G. Cooke

Published in: Breast Cancer Research and Treatment | Issue 3/2009

Login to get access

Abstract

The incidence of breast cancer in post-menopausal women has been affected by the introduction of national breast screening programmes. The study describes the incidence of breast cancer in Scottish women aged 50–64 by year of birth before, during, and after the prevalent round of screening. Breast cancer registrations in Scotland for women aged 45–69 years from 1977 to 2003 were obtained. Birth cohort incidence rates were calculated and interpreted in the light of screening patterns at particular calendar time points. In the years before screening, there was a small rise in breast cancer incidence by birth cohort in women aged 50–54 which was not seen in other ages. During the prevalent screening round, incidence increased significantly with increasing birth cohort and thereafter continued rises in incidence by birth cohort occurred. The observed rise in breast cancer incidence among post-menopausal women is likely to be due to both screening effects and a true increase in incidence.
Literature
1.
go back to reference Breast cancer incidence data (2005) Scottish Executive Information & Statistics Division, Scotland Breast cancer incidence data (2005) Scottish Executive Information & Statistics Division, Scotland
2.
go back to reference Brown SBF, Hole DJ, Cooke TG (2006) Breast cancer incidence trends in deprived and affluent Scottish women. Breast Cancer Res Treat 103(2):233–238PubMedCrossRef Brown SBF, Hole DJ, Cooke TG (2006) Breast cancer incidence trends in deprived and affluent Scottish women. Breast Cancer Res Treat 103(2):233–238PubMedCrossRef
3.
go back to reference Swerdlow AJ, dos Santos Silva I, Reid A, Qiao Z, Brewster DH, Arrundale J (1998) Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer 77(Suppl 3):1–54PubMed Swerdlow AJ, dos Santos Silva I, Reid A, Qiao Z, Brewster DH, Arrundale J (1998) Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer 77(Suppl 3):1–54PubMed
5.
go back to reference Schouten LJ, de Rijke JM, Huveneers JA, Verbeek AL (2002) Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme. J Med Screen 9:120–124. doi:10.1136/jms.9.3.120 PubMedCrossRef Schouten LJ, de Rijke JM, Huveneers JA, Verbeek AL (2002) Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme. J Med Screen 9:120–124. doi:10.​1136/​jms.​9.​3.​120 PubMedCrossRef
6.
go back to reference Chia KS, Reilly M, Tan CS, Lee J, Pawitan Y, Adami HO et al (2005) Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113:302–306. doi:10.1002/ijc.20561 PubMedCrossRef Chia KS, Reilly M, Tan CS, Lee J, Pawitan Y, Adami HO et al (2005) Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113:302–306. doi:10.​1002/​ijc.​20561 PubMedCrossRef
8.
go back to reference Rosner B, Colditz GA, Willett WC (1994) Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol 139:819–835PubMed Rosner B, Colditz GA, Willett WC (1994) Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol 139:819–835PubMed
9.
go back to reference Pathak DR, Whittemore AS (1992) Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol 135:153–168PubMed Pathak DR, Whittemore AS (1992) Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol 135:153–168PubMed
10.
go back to reference Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303:767–770. doi:10.1038/303767a0 PubMedCrossRef Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303:767–770. doi:10.​1038/​303767a0 PubMedCrossRef
12.
go back to reference Newcombe RG, Altman DG (2000) Proportions and their differences. In: Altman D, Machin D, Bryant T, Gardner S (eds) Statistics with confidence, Ch 6, 2nd edn. BMJ Books, London Newcombe RG, Altman DG (2000) Proportions and their differences. In: Altman D, Machin D, Bryant T, Gardner S (eds) Statistics with confidence, Ch 6, 2nd edn. BMJ Books, London
13.
go back to reference dos Santos Silva I, Swerdlow AJ (1995) Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 72:485–492PubMed dos Santos Silva I, Swerdlow AJ (1995) Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 72:485–492PubMed
14.
go back to reference Cumulative fertility data at age 44 by maternal birth cohort (2006) General Register Office-Scotland Cumulative fertility data at age 44 by maternal birth cohort (2006) General Register Office-Scotland
15.
17.
go back to reference Townsend J (1998) Hormone replacement therapy: assessment of present use, costs, and trends. Br J Gen Pract 48:955–958PubMed Townsend J (1998) Hormone replacement therapy: assessment of present use, costs, and trends. Br J Gen Pract 48:955–958PubMed
18.
go back to reference Townsend J, Nanchahal K (2005) Hormone replacement therapy: limited response in the UK to the new evidence. Br J Gen Pract 55:555PubMed Townsend J, Nanchahal K (2005) Hormone replacement therapy: limited response in the UK to the new evidence. Br J Gen Pract 55:555PubMed
Metadata
Title
Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme
Authors
Sylvia B. F. Brown
David S. Morrison
Timothy G. Cooke
Publication date
01-08-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0205-0

Other articles of this Issue 3/2009

Breast Cancer Research and Treatment 3/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine